BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27391101)

  • 21. Cholinergic Neurons of the Medial Septum Are Crucial for Sensorimotor Gating.
    Jin J; Cheng J; Lee KW; Amreen B; McCabe KA; Pitcher C; Liebmann T; Greengard P; Flajolet M
    J Neurosci; 2019 Jun; 39(26):5234-5242. PubMed ID: 31028115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function.
    Bickel S; Lipp HP; Umbricht D
    Neuropsychopharmacology; 2008 Jun; 33(7):1680-9. PubMed ID: 17712349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
    Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing.
    Klamer D; Svensson L; Fejgin K; Pålsson E
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):248-53. PubMed ID: 21111580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome.
    Kimoto S; Muraki K; Toritsuka M; Mugikura S; Kajiwara K; Kishimoto T; Illingworth E; Tanigaki K
    Transl Psychiatry; 2012 Aug; 2(8):e146. PubMed ID: 22872161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental GABAergic deficit enhances methamphetamine-induced apoptosis.
    Abekawa T; Ito K; Nakato Y; Koyama T
    Psychopharmacology (Berl); 2011 Jun; 215(3):413-27. PubMed ID: 21487660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.
    Wolf R; Paelchen K; Matzke K; Dobrowolny H; Bogerts B; Schwegler H
    Psychopharmacology (Berl); 2007 Sep; 194(1):93-102. PubMed ID: 17541558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
    Uehara T; Sumiyoshi T; Seo T; Matsuoka T; Itoh H; Suzuki M; Kurachi M
    Brain Res; 2010 Sep; 1352():223-30. PubMed ID: 20633540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hearing loss in a mouse model of 22q11.2 Deletion Syndrome.
    Fuchs JC; Zinnamon FA; Taylor RR; Ivins S; Scambler PJ; Forge A; Tucker AS; Linden JF
    PLoS One; 2013; 8(11):e80104. PubMed ID: 24244619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine H
    Aquino-Miranda G; Rivera-Ramírez N; Márquez-Gómez R; Escamilla-Sánchez J; González-Pantoja R; Ramos-Languren LE; Perez-Neri I; Bueno-Nava A; Ríos C; Arias-Montaño JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109653. PubMed ID: 31108178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.
    Nilsson SRO; Celada P; Fejgin K; Thelin J; Nielsen J; Santana N; Heath CJ; Larsen PH; Nielsen V; Kent BA; Saksida LM; Stensbøl TB; Robbins TW; Bastlund JF; Bussey TJ; Artigas F; Didriksen M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2151-2163. PubMed ID: 26983414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.
    Bakshi VP; Geyer MA
    J Neurosci; 1998 Oct; 18(20):8394-401. PubMed ID: 9763482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.
    Nielsen J; Fejgin K; Sotty F; Nielsen V; Mørk A; Christoffersen CT; Yavich L; Lauridsen JB; Clausen D; Larsen PH; Egebjerg J; Werge TM; Kallunki P; Christensen KV; Didriksen M
    Transl Psychiatry; 2017 Nov; 7(11):1261. PubMed ID: 29187755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats.
    Schwabe K; Koch M
    Neurosci Lett; 2004 Jan; 355(1-2):5-8. PubMed ID: 14729221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
    Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
    Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
    Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
    Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal dopamine receptor plasticity in neurotensin deficient mice.
    Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
    Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.
    Pietraszek M; Michaluk J; Romańska I; Wasik A; Gołembiowska K; Antkiewicz-Michaluk L
    Neurotox Res; 2009 Nov; 16(4):390-407. PubMed ID: 19649683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.